INEZETAMAB
UNII DZY93T274S

Substance Identification & Data

This profile provides standardized clinical and technical data for Inezetamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DZY93T274S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2568264-76-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
DZY93T274S
CAS Registry Number
2568264-76-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
INEZETAMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C180531
National Cancer Institute reference terminology for clinical and research data.
INN ID
12088
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Inezetamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INEZETAMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (295-CYSTEINE,300-GLYCINE,305-CYSTEINE,DE-450-LYSINE), ANTI-(HUMAN CD40 ANTIGEN) (HUMAN CLONE 30A12 .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGSGGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN MESOTHELIN) (HUMAN CLONE 6F4 SINGLE-CHAIN VARIABLE FRAGMENT VH-(GGGGS)3-VL), DISULFIDE WITH HUMAN CLONE 30A12 .LAMBDA.-CHAIN, DIMER
INEZETAMAB [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus